Malignant Neoplasms
20
7
8
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
10.0%
2 terminated out of 20 trials
60.0%
-26.5% vs benchmark
5%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (20)
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Safety and Performance Evaluation of the RonovoTM Robotic Surgical Platform in Oncological Procedures
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Body Composition and Setup Errors in Radiotherapy
A Study of DEG6498 in Participants With Solid Tumors
Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases
A Multi Center Study of Sexual Toxicities After Radiotherapy
Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors
An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma
A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors
Validation of the Italian Version of the PRO-CTCAE
A Phase 1,Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer
Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary Stent
Efficacy and Safety of the Paclitaxel Eluting Covered Biliary Stent to the Common Covered Metallic Biliary Stent
The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients
Community Cancer Centers Pilot Patient Survey